Abstract:BACKGROUND: Primary dystonia is a heterogeneous disease, with a complex genetic basis. In previous studies, primary dystonia was classified according to age of onset involved regions, and other clinical characteristics. With the development of molecular genetics, new virulence genes and sites have been discovered. Therefore, there is a gradual understanding of the various forms of dystonia, based on new viewpoints. There are 15 subtypes of dystonia based on the molecular level, i.e., DYT1 to DYT15.OBJECTIVE: To analyze the genetic development of dystonia in detail, and to further investigate molecular mechanisms of dystonia.RETRIEVAL STRATEGY: A computer-based online search was conducted in PubMed for English language publications containing the keywords "dystonia and genetic" from January 1980 to March 2007. There was 105 articles in total. Inclusion criteria: (1) the contents of the articles should closely address genetic classification and molecular mechanisms of primary dystonia: (2) the articles published in recent years or in high-impact journals took preference. Exclusion criteria: duplicated articles.LITERATURE EVALUATION: The selected articles were on genetic classification and molecular genetics mechanism of primary dystonia. Of those 27 were basic or clinical studies.DATA SYNTHESIS: (1) Dystonia is a heterogeneous disease with a complex genetic basis. According to the classification of the Human Genome Organization, there 15 dystonia subtypes, based on genetics, i.e.. DYT1-DYT15, including primary dystonia, dystonia plus syndrome degeneration plus dystonia and paroxysmal dyskinesia plus dystonia. (2) To date, the chromosomes of 13 subtypes have been localized: however, DYT2 and DYT4 remain unclear. Six subtypes have been located within virulence genes. Specifically, torsinA gene expression results in the DYT1 genotype: autosomal dominant GTP cyclohydrolase 1 gene expression and recessive tyrosine hydroxylase expression result in the DYT5 genotype respectively; the epsilon-sarcoglycan gene is involved in DYT11: Na(+)/K(+)-ATP enzyme a 3 chain gene in DYT12; TATA-conjugated protein-associated factor 1 gene in DYT3; and myofibril regulatory factor gene in DYT8. (3) Different types of dystonia exhibit various clinical characteristics and specific clinical manifestations. (4) Many elements regarding the molecular mechanism of dystonia have been determined. However, many components remain poorly understood. For example detailed pathogenesis remains unclear. Various forms of dystonia exhibit similar problems. Moreover, a single form of dystonia may be a result of two or more different chromosomal mutations. In addition, more studies are needed to fully understand chromosome apposition and virulence genes involved in dystonia.CONCLUSION: The discovery of virulence genes and localizations of newly classified forms of dystonia are beneficial to further understanding the molecular mechanisms of dystonia.

Role of Dyt1 Gene in Early-Onset Primary Torsion Dystonia

ATP1A3 Mutation in Rapid-Onset Dystonia Parkinsonism: New Data and Genotype-Phenotype Correlation Analysis

Behavioral and Electrophysiological Characterization of Dyt1 Heterozygous Knockout Mice

Untethering the Nuclear Envelope and Cytoskeleton: Biologically Distinct Dystonias Arising from a Common Cellular Dysfunction

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

Atypical Phenotype Of 3bp Deletion And Burden Analysis Of Rare Variants In The Exon 5 Of Dyt1 In Primary Dystonia

Intracellular Complexes of the Early-Onset Torsion Dystonia-Associated AAA+ ATPase TorsinA.

Clinical and Genetic Evaluation of DYT1 and DYT6 Primary Dystonia in China

DYT1 MUTATIONS AMONGST EARLY ONSET PRIMARY DYSTONIA PATIENTS IN CHINA

A Novel Tyrosine Hydroxylase Variant in a Group of Chinese Patients with Dopa-Responsive Dystonia.

Combined Occurrence of a Novel TOR1A and a THAP1 Mutation in Primary Dystonia

Subcellular distribution of THAP1 and alterations in the microstructure of brain white matter in DYT6 dystonia

Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia

Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice

Gene-environment interaction elicits dystonia-like features and impaired translational regulation in a DYT-TOR1A mouse model

Genetic Classification and Molecular Mechanisms of Primary Dystonia

[Tyrosine Hydroxylase Deficiency: a Case of Autosomal Recessive Dopa-Responsive Dystonia].

Association of Rs1182 Polymorphism of the DYT1 Gene with Primary Dystonia in Chinese Population.

The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro

Allele-specific targeting of mutant TOR1A by the compact CRISPR/NmCas9 system in DYT1 dystonia with high fidelity

Generation of Patient-Specific Induced Pluripotent Stem Cell Line (Csui002-A) from a Patient with Isolated Dystonia Carrying TOR1A Mutation.